EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spatiotemporal Epidemiology of Lumpy Skin Disease and Evaluation of the Heterologous Goatpox Vaccine: Insights into Immunogenicity and Impact

Manjunatha Reddy Gundallahalli Bayyappa iD, Sai Mounica Pabbineedi iD, Sudeep Nagaraj iD, Shraddha Bijalwan iD, Sunil Tadakod iD, Chandana Ramesh Uma iD, Sanjay Pawar, Pathan Yahaya Khan, Vijay Kumar Teotia, Baldev Raj Gulati iD

Vaccines · 13.06.2025 · 13 (6) · 641

DOI: 10.3390/vaccines13060641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 13.06.2025. Verfasst von Manjunatha Reddy Gundallahalli Bayyappa und 9 weiteren Autor:innen. Beteiligte Einrichtung: ICAR-National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI), Bengaluru 560064, India. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Livestock Mission, ICAR-National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI) under the Indian Council of Agricultural Research (ICAR), National Livestock Mission, DAHD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lumpy skin disease (LSD) is major transboundary disease affecting cattle and water buffaloes, indirectly causing huge socio-economic losses. Following its first outbreak in India in 2019, the heterologous Goatpox (Uttarkashi strain) vaccine mitigated LSD.

Objective

Due to limited data on the spatiotemporal distribution of the disease, this study investigates its dynamics and presents findings from a field study conducted in Maharashtra, India. This study evaluates the safety, immunogenicity, and duration of immunity provided by a heterologous vaccine. Additionally, it examines post-vaccination responses in relation to factors such as age, gender, and breed.

Methods

This study employed spatiotemporal analysis of lumpy skin disease (LSD) outbreaks from 2020 to 2024 using GeoDa (v1.22), incorporating Moran’s I and Getis-Ord Gi* statistics to identify spatial clustering patterns. A randomized field trial was conducted to evaluate vaccine safety and immunogenicity in 657 cattle across seven districts. Humoral immune responses were assessed using the serum neutralization test (SNT) and indirect enzyme-linked immunosorbent assay (ELISA), while cell-mediated immunity was evaluated via Interferon-gamma (IFN-γ) ELISA. For sero-monitoring, a total of 1925 serum samples from 22 districts were analyzed. Additionally, statistical analyses (n = 1925), including the Kappa Index, ANOVA, and logistic regression, were performed using SPSS v27 to investigate the influence of factors such as age, sex, and breed (significance level: p < 0.05).

Results

LSD exhibited significant spatial clustering across Maharashtra. The Goatpox vaccine was 100% safe, with no adverse reactions. Protective antibody titers (≥1:8) were observed in 96.9% of vaccinated cattle by 14–21 days post-vaccination (dpv), peaking at 60 dpv before declining at 150 dpv. The cell-mediated immune response peaked at 28 dpv. Clinical monitoring for one year showed that only 2% of vaccinated cattle developed mild LSD symptoms after nine months, with no mortality. At six months post-vaccination, seroconversion was 69.7%, with breed significantly influencing seropositivity.

Conclusions

This study confirms the Goatpox vaccine’s safety and strong immunogenicity in cattle, marking its first large-scale evaluation in the Indian subcontinent. Further research is needed to assess long-term immunity and protection against virulent LSD strains.

Schlagwörter

Stichwörter der Autor:innen

cell-mediated immune responsehumoral immune responseimmunogenicitylumpy skin diseasespatial analysistemporal analysisvaccination

Autor:innen und Institutionen

  • ICAR-National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI), Bengaluru 560064, India.
  • Western Regional Disease Diagnostic Laboratory, State Level Animal Disease Investigation Laboratory, Aundh, Pune 411067, India.
  • Department of Animal Husbandry and Dairying, Ministry of Fisheries, Animal Husbandry and Dairying, New Delhi 110001, India.

ORCID-Profile: Manjunatha Reddy Gundallahalli Bayyappa, Sai Mounica Pabbineedi, Sudeep Nagaraj, Shraddha Bijalwan, Sunil Tadakod, Chandana Ramesh Uma, Baldev Raj Gulati

Förderung

  • National Livestock Mission
  • ICAR-National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI) under the Indian Council of Agricultural Research (ICAR)
  • National Livestock Mission, DAHD

Zitieren

APA

Bayyappa, M. R. G., Pabbineedi, S. M., Nagaraj, S., Bijalwan, S., Tadakod, S., Uma, C. R., Pawar, S., Khan, P. Y., Teotia, V. K., & Gulati, B. R. (2025). Spatiotemporal Epidemiology of Lumpy Skin Disease and Evaluation of the Heterologous Goatpox Vaccine: Insights into Immunogenicity and Impact. Vaccines, 13(6), 641. https://doi.org/10.3390/vaccines13060641

Vancouver

Bayyappa MRG, Pabbineedi SM, Nagaraj S, Bijalwan S, Tadakod S, Uma CR, et al. Spatiotemporal Epidemiology of Lumpy Skin Disease and Evaluation of the Heterologous Goatpox Vaccine: Insights into Immunogenicity and Impact. Vaccines. 2025;13(6):641. doi:10.3390/vaccines13060641

BibTeX
@article{Bayyappa2025,
  author = {Bayyappa, Manjunatha Reddy Gundallahalli and Pabbineedi, Sai Mounica and Nagaraj, Sudeep and Bijalwan, Shraddha and Tadakod, Sunil and Uma, Chandana Ramesh and Pawar, Sanjay and Khan, Pathan Yahaya and Teotia, Vijay Kumar and Gulati, Baldev Raj},
  title = {Spatiotemporal Epidemiology of Lumpy Skin Disease and Evaluation of the Heterologous Goatpox Vaccine: Insights into Immunogenicity and Impact},
  journal = {Vaccines},
  year = {2025},
  volume = {13},
  number = {6},
  pages = {641},
  doi = {10.3390/vaccines13060641}
}
Kostenlos starten →